NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
This Quarter Return
+11.4%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$713M
AUM Growth
+$713M
(-7.2%)
Cap. Flow
-$97.8M
Cap. Flow
% of AUM
-13.71%
Top 10 Holdings %
Top 10 Hldgs %
96.7%
Holding
19
New
2
Increased
3
Reduced
–
Closed
5
Top Buys
| 1 |
OrthoPediatrics
KIDS
|
$7.27M |
| 2 |
Akebia Therapeutics
AKBA
|
$5.02M |
| 3 |
Glaukos
GKOS
|
$4.01M |
| 4 |
DERM
Dermira, Inc.
DERM
|
$1.75M |
| 5 |
NBRV
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
|
$126K |
Top Sells
| 1 |
AnaptysBio
ANAB
|
$41.6M |
| 2 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$36.3M |
| 3 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$18.4M |
| 4 |
KalVista Pharmaceuticals
KALV
|
$18.3M |
| 5 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$1.29M |
Sector Composition
| 1 | Healthcare | 91.29% |
